Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May-Jun;74(3):170-177.
doi: 10.1016/j.ihj.2022.04.008. Epub 2022 Apr 29.

Cardiac complications of COVID-19: Incidence and outcomes

Affiliations

Cardiac complications of COVID-19: Incidence and outcomes

Jayasree Pillarisetti et al. Indian Heart J. 2022 May-Jun.

Abstract

Background: Coronavirus disease-2019 (COVID-19) has been associated with pre-existing cardiac conditions as well as cardiovascular complications. The incidence rates of cardiac complications, age, and gender differences in this population are unknown.

Objectives: We wanted to study the incidence of cardiac complications and mortality in patients with COVID-19.

Methods: Data from the TriNetX COVID-19 global research network platform was used to identify COVID-19 patients. We compared patients with and without cardiac complications in patients with COVID-19 and obtained survival data.

Results: The final cohort was composed of 81,844 patients with COVID-19. Cardiac complications occurred in 9.3% of patients as follows: acute coronary syndromes in 1.3%, heart failure in 4.4%, atrial fibrillation in 4.5%, sinus bradycardia 1.9%, ventricular tachycardia in 0.5% and complete heart block in 0.01%. Mortality was significantly higher in patients with the cardiac complications mentioned (20%) than in those without them (2.9%) (odds ratio 7.2, 95% CI, 6.7-7.7; p < 0.0001). Older males seem to have higher incidence of cardiac complications and mortality.

Conclusions: Patients with COVID-19 who have cardiac complications have a higher risk of mortality when compared to those without cardiac complications.

Keywords: COVID-19; Cardiac complications; Mortality; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Incidence of cardiac Complications of COVID-19.
Fig. 2
Fig. 2
a. New onset cardiac complications. b. Number of de novo events and total events (se novo and recurrent).
Fig. 3
Fig. 3
Number of Health Care Organizations from which data is obtained.
Fig. 4
Fig. 4
b. Propensity Matched Kaplan Meier survival curves for patients with and without cardiac complications.

References

    1. Wu Z., McGoogan M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. - PubMed
    1. Zhu N., Zhang D., Wang W., et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. - PMC - PubMed
    1. Mousavizadeh L., Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. J Microbiol Immunol Infect. 2020;54(2):159–163. - PMC - PubMed
    1. https://ourworldindata.org/covid-cases
    1. Guan W.J., Ni Z.Y., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. - PMC - PubMed

LinkOut - more resources